When Syneos Health fired employees who refused to get vaccinated for COVID-19, it allowed Florida residents to keep working. Presumably, the company was following Florida’s law, enacted in November, prohibiting private employers from mandating COVID-19 vaccines. Under Florida’s law, businesses with 99 employees or less face a fine of $10,000 per employee violation, while larger…
Fired Syneos Health Workers: Company Ignored Tennessee Vaccination Law
February 5, 2022
admin
AMERICABusiness & EconomyBusinesses in COVID-19CCP Virusconstitutional rightsefficacyFeatured TopicspharmaceuticalPolicies & ImpactsTennesseeUSUS NewsVaccineVaccines & Safety
0 Comment
If You Invested $1,000 in Catalyst Pharmaceuticals Stock One Year Ago, Here’s How Much You’d Have Now
Investors who have owned stocks in the last year have generally experienced some big gains. In fact, the SPDR S&P 500 ETF Trust total return over the last 12 months is 29.5 percent. But there is no question some big-name stocks performed better than others along the way. Catalyst’s Bumpy Ride One company that has…
Bipartisan Bill Seeks to Make US Pharmaceutical Supply Chain Less Dependent on Foreign Countries Like China
A bipartisan group of lawmakers on Wednesday reintroduced a bill that would make the U.S. pharmaceutical supply chain less dependent on foreign countries like China. The legislation will help mitigate drug shortages while incentivizing the domestic production of drugs, active pharmaceutical ingredients (API), personal protective equipment (PPE), and diagnostics, according to Rep. Earl L. “Buddy” Carter (R-Ga.), one of…
Lack of Domestic Vaccines Has Raised Calls for Pharmaceutical Policy Reforms, While Some Advise Caution
The lack of Canadian capacity to produce COVID-19 vaccines has raised new questions on how governments should approach the pharmaceutical industry. Amid calls for Canada to create a better investment environment for pharmaceutical companies, some are advising caution to avoid overcompensation and a culture that could foster over-prescription, instead suggesting a more results-based approach. Walter…
Are Digital Pills in Your Future?
In November 2017, the FDA approved the digital pill Abilify MyCite to treat schizophrenia, depression, and bipolar disorder(1); a one-month supply costs $1,500, well out of range of affordability for many suffering from schizophrenia(2). The pill includes a digital sensor that reacts with stomach acid when taken, sending a signal to a patch worn by…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`